Cargando…
Death of a tumor: targeting CCN in pancreatic cancer
The matricellular protein CCN2 (connective tissue growth factor, CTGF) has been previously implicated in tumorigenesis. In pancreatic cancer cells, CCN2 expression occurs downstream of ras/MEK/ERK. Direct evidence that CCN2 mediates tumor progression in pancreatic cancer has been lacking. An excitin...
Autor principal: | Leask, Andrew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721081/ https://www.ncbi.nlm.nih.gov/pubmed/19267221 http://dx.doi.org/10.1007/s12079-009-0042-x |
Ejemplares similares
-
The skinny on CCN2
por: Leask, Andrew
Publicado: (2008) -
Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2
por: Leask, Andrew
Publicado: (2009) -
What’s in an intron? CCN1 mRNA splicing in cancer
por: Leask, Andrew
Publicado: (2009) -
Thrombin-induced CCN2 expression as a target for anti-fibrotic therapy in scleroderma
por: Leask, Andrew
Publicado: (2009) -
Trial by CCN2: a standardized test for fibroproliferative disease?
por: Leask, Andrew
Publicado: (2009)